Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Semler Dirty Data: EMA Suspends Over 200 Products; Stings Indian CROs

Executive Summary

Dirty data issues continue to plague Indian contract research organizations, denting the reputation of the beleaguered local industry and piling up challenges for marketing authorization holders. The European Medicines Agency (EMA) has now suspended close to 300 products that relied on flawed bioequivalence studies done by the Bengaluru-based Semler Research.

Advertisement

Related Content

Top FDA Compliance Official Notes 'Revival' Of Data Integrity Fraud
India’s Micro Therapeutic says EMA’s ‘Sweep’ Suspension Will Hurt; CRO Industry Shuns ‘Bad Eggs’
Indian Clinical Research Sector: Hope And Despair Amid Shutdowns
India Tweaks More Trial Rules But Can It Change The Narrative?
Foreign Regulators Rap More Indian Firms Over Data Integrity
GVK India Row: Stalled EU Trade Talks And ''Vendetta'' Claims
EU confirms suspension of 700 products hit by Indian CRO issues
The ECG curse: India's Quest under lens in ''retrospective'' finding
Indian CRO segment in throes of a shakeout?

Topics

Advertisement
UsernamePublicRestriction

Register

SC096972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel